希羅欣"山德士"靜脈輸注液2毫克/毫升

国家: 台湾

语言: 中文

来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

资料单张 资料单张 (PIL)
21-12-2020
公众评估报告 公众评估报告 (PAR)
13-04-2020

有效成分:

CIPROFLOXACIN (HCL)

可用日期:

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589)

ATC代码:

J01MA02

药物剂型:

注射劑

组成:

CIPROFLOXACIN (HCL) (0812709710) (2.218mg) (potency)MG

每包单位数:

玻璃小瓶裝

类:

製 劑

处方类型:

限由醫師使用

厂商:

SOLUPHARM PHARMAZEUTISCHE ERZEUGNISSE GMBH INDUSTRIESTRABE 3, 34212 MELSUNGEN, GERMANY DE

治疗领域:

ciprofloxacin

疗效迹象:

成人:對Ciprofloxacin有感受性細菌所引起之呼吸道感染、中耳炎、竇炎、眼感染、腎臟及泌尿道感染﹝包括淋病﹞、腹部感染﹝包括腸炎、膽囊炎、腹膜炎﹞、皮膚及軟組織感染、骨髓炎、關節感染、菌血症。小孩:大腸桿菌引起之複雜性泌尿道感染和腎盂腎炎﹝1-17歲﹞、綠膿杆菌有關之囊腫性纖維化產生急性肺部惡化的現象﹝5-17歲﹞。成人和小孩:吸入性炭疽病﹝接觸後﹞。

產品總結:

註銷日期: 2020/04/06; 註銷理由: 自請註銷; 有效日期: 2023/09/30; 英文品名: Ciprofloxacin Sandoz 2mg/ml Solution for Infusion

授权状态:

已註銷

授权日期:

2013-09-30

资料单张

                                1.
“” 2/
2.
100221.8ciprofloxacin hydrochloride
200
Ciprofloxacin
400(15.6)
3.
“” 2/
4.
4.1
ciprofloxacin
(
)
(
)
[ ]
-
(Pneumococcus)
ciprofloxacin
(
_Klebsiella spp._
)
(
_Enterobacter spp._
)(
_Proteus spp._
)(
_Escherichia _
_coli_
)
(
_Pseudomonas aeruginosa_
)
(
_Haemophilus spp._
)
Moraxella
catarrhalisLegionella
(Staphylococci)
ciprofloxacin
-
(
)
(
)
(
_Pseudomonas _
_aeruginosa_
) (Staphylococci)
-
- /
-
- ()
-
-
-
-
(
)
-
- (
_Escherichia coli_
)(1-17)
-
(
_P. aeruginosa_
)
(5-17
)
[ ]
/
/
- ()
[ ]
Ciprofloxacin
4.2
CIPROFLOXACIN
TIZANIDINE (
“
”)
4.4 ()
QUINOLONE
FLUOROQUINOLONE
/
CIPROFLOXACIN
CIPROFLOXACIN
CIPROFLOXACIN
FLUOROQUINOLONE
(NEISSERIA GONORRHOEAE ISOLATES)
CIPROFLOXACIN
CIPROFLOXACIN
QT
(
“
”)
QTC(BASELINE QTC INTERVAL)
QTC
QT
CIPROFLOXACIN
QT
(
CLASS IA OR III
) (
)QTTORSADE DE POINTS
(
QT
[
]
[
)
(1-17)
CIPROFLOXACIN
(WEIGHT-BEARING JOINT)
(
“
”)
CIPROFLOXACIN
(
18
)
CIPROFLOXACIN
(
5-17
)
(1-17)()
(
)
/
CIPROFLOXACIN
CIPROFLOXACIN
(
“
”)
(
“
”)
CIPROFLOXACIN
()
(
)
(
“
”)
CIPROFLOXACIN
(
4 × 250
VANCOMYCIN)
CIPROFLOXACIN(HEPATIC NECROSIS)
(
)
(
“
”)
CIPROFLOXACIN
(TRANSAMINASES)
(ALKALINE
PHOSPHATASE)(CHOLESTATIC
JAUNDICE)
*
CIPROFLOXACIN
(WEIGHT-
BEARING JOINT) CIPROFLOXACIN(18
)
(
)
FLUOROQUINOLONE
48
(
)
(
)
(TENDINOPATHY)
(
)
CIPROFLOXACIN
()
(
)
CIPROFLOXACIN
QUINOLONE
CIPROFLOXACINFLUOROQUINOLONES
(
)
CIPROFLOXACIN
(STATUS EPILEPTICUS)(“”)
CIPROFLOXACIN
FLUOROQUINOLONE
/
FLUOROQUINOLONE
(
)
(
)
(
)
(
)
CIPROFLOXACINFLUOROQUINOLONES
(POLYNEUROPATHY)
CIPROFLOXACIN
(
)
CIPROFLOXACIN
CIPROFLOXACIN
(
)
(“”)
CYTOCHROME P450
CIPROFLOXACIN
CYP 450 1A2
(
TIZANIDINE
THEOPHYLLINE
METHYLXANTINES
CAFFEINE
DULOXETINE
ROPINIROLE
CLOZAPINE
OLANZAPINE
AGOMELATINE)
CIPROFLOXACIN
(“”)
CIPROFLOXACIN
30
CIPROFLOXACIN
(_MYCOBACTERIAL _
_TUBERCULOSIS_)
(MYCOBACTERIUM SPP.)
CIPROFLOXACIN
FLUOROQUINOLONE
(
GLYBURIDE)
FLUOROQUINOLONE
/
(
MARFAN SYNDROME
VASCULAR ENLERS-DANLOS SYNDROME
TAKAYASU ARTERITIS
GIANT CELL ARTERITIS
BEHCET’S
DISEASE)FLUOROQUINOLO
                                
                                阅读完整的文件